S. Dertkigil

Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial

L. Velloso, T. Benaglia, M. Monfort-Pires, 2021, Trials.

Circulating Levels of Ang/Tie2 and VEGF-a Pathway Mediators Are Associated with Clinical Severity, Endothelial Barrier Disruption and Coagulation Activation in COVID-19

L. Velloso, E. Mansour, L. C. Ribeiro, 2021, Blood.

Angiopoietin2 is associated with coagulation activation and tissue factor expression in extracellular vesicles in COVID-19

A. Ilich, J. Annichino-Bizzacchi, Franciéle de Lima, 2024, Frontiers in medicine.

Association of heme-oxygenase 1, hemopexin, and heme levels with markers of disease severity in COVID-19

J. Annichino-Bizzacchi, E. Mansour, A. Palma, 2023, Experimental biology and medicine.

Pharmacological inhibition of the kinin-kallikrein system in severe COVID-19 A proof-of-concept study

L. Velloso, M. Monfort-Pires, E. Araujo, 2020, medRxiv.